We hypothesize that the effectiveness of antioxidant defense is associated with the expression of estrogen and progesterone receptors and is reduced in prognostically unfavorable breast cancer subtypes (Non-Lum and TNBC). The gene discussed is PGR; the disease is breast cancer.